Can sleep apnea explain high hematocrit, fatigue, or poor results on TRT?
Interrupted breathing can be an overlooked contributor when changing testosterone does not solve the problem.
Sleep apnea can contribute to persistent fatigue and may compound a rising hematocrit during testosterone treatment. Repeated airway obstruction fragments sleep and can lower oxygen levels overnight. Testosterone can independently increase red-cell production, so these influences may coexist. In a retrospective study of men receiving TRT, obstructive sleep apnea was associated with polycythemia. An association does not establish the cause in every individual, and high hematocrit alone cannot diagnose apnea or tell how severe it is.[1][2]
Loud snoring, witnessed breathing pauses, waking unrefreshed and daytime sleepiness are reasons to consider a sleep evaluation, particularly when fatigue persists despite adequate hormone replacement. The assessment may require a home sleep-apnea test or laboratory study. Increasing testosterone to overcome unexplained fatigue can miss the underlying problem. Likewise, blood donation lowers hematocrit without treating interrupted breathing. The Endocrine Society guideline treats untreated severe obstructive sleep apnea as an important concern when considering testosterone therapy.[2][3]
Sources & further reading
- Sleep apnea and polycythemia in men receiving TRT
- NHLBI: sleep apnea
- Endocrine Society: testosterone therapy guideline
Updated September 24, 2026 · Evidence summaries for understanding research.